JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M106339200 on November 26, 2001

J. Biol. Chem., Vol. 277, Issue 4, 2695-2701, January 25, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/4/2695    most recent
M106339200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbert, L.
Right arrow Articles by Nanes, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbert, L.
Right arrow Articles by Nanes, M. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha *

Linda GilbertDagger , Xiaofei HeDagger , Paul FarmerDagger , Janet RubinDagger , Hicham Drissi§, Andre J. van Wijnen§, Jane B. Lian§, Gary S. Stein§, and Mark S. NanesDagger

From the Dagger  Division of Endocrinology and Metabolism, Emory University School of Medicine and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia 30033 and the § Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655

The transcription factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is a critical regulator of osteoblast differentiation. We investigated the effect of the inflammatory cytokine tumor necrosis factor alpha  (TNF) on the expression of RUNX2 because TNF is known to inhibit differentiation of osteoblasts from pluripotent progenitor cells. TNF treatment of fetal calvaria precursor cells or MC3T3-E1 clonal pre-osteoblastic cells caused a dose-dependent suppression of RUNX2 steady state mRNA as measured by reverse transcription-PCR. The IC50 for TNF inhibition was 0.6 ng/ml. TNF suppression of RUNX2 mRNA was confirmed using Northern analysis. The effect of TNF was studied using isoform-specific primers that flanked unique regions of two major RUNX2 isoforms. TNF suppressed expression of the mRNA coding for the shorter MRIPV isoform by >90% while inhibiting expression of the mRNA for the longer MASNS isoform by 50%. RUNX2 nuclear content was evaluated by electrophoretic mobility shift assay using a rat osteocalcin promoter binding sequence as probe and by Western analysis. TNF reduced nuclear RUNX2 protein. Inhibition of new protein synthesis with cycloheximide failed to prevent TNF inhibition of RUNX2 mRNA, suggesting that a newly translated protein did not mediate the TNF effect. RUNX2 mRNA half-life was 1.8 h and reduced to 0.9 h by TNF. The effect of TNF on RUNX2 gene transcription was evaluated using a 0.6-kb RUNX2 promoter-luciferase reporter in MC3T3-E1 cells. TNF caused a dose-dependent inhibition of transcription to 50% of control values. The inhibitory effect of TNF was preserved with deletions to nucleotide -108 upstream of the translational start site; however, localization downstream of nucleotide -108 was obscured by loss of basal activity. Our results indicate that TNF regulates RUNX2 expression at multiple levels including destabilization of mRNA and suppression of transcription. The disproportionate inhibition of RUNX2 nuclear protein suggests that additional post-transcriptional mechanisms may be occurring. Suppression of RUNX2 by TNF may decrease osteoblast differentiation and inhibit bone formation in TNF excess states.


* This work was supported by National Institutes of Health Grant R01 AR46452-01 and a Department of Veterans Affairs Merit Review grant (both to M. S. N.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Div. of Endocrinology and Metabolism, Veterans Affairs Medical Center (111), 1670 Clairmont Rd., Decatur, GA 30033. E-mail: mnanes@emory.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Guo, M. Yamashita, Q. Zhang, Q. Zhou, D. Chen, D. G. Reynolds, H. A. Awad, L. Yanoso, L. Zhao, E. M. Schwarz, et al.
Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins
J. Biol. Chem., August 22, 2008; 283(34): 23084 - 23092.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Hewitt, X. Lu, L. Gilbert, and M. S. Nanes
The Muscle Transcription Factor MyoD Promotes Osteoblast Differentiation by Stimulation of the Osterix Promoter
Endocrinology, July 1, 2008; 149(7): 3698 - 3707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yu, Y. Jiang, D. L. Galson, M. Luo, Y. Lai, Y. Lu, H.-J. Ouyang, J. Zhang, and G. Xiao
General Transcription Factor IIA-{gamma} Increases Osteoblast-specific Osteocalcin Gene Expression via Activating Transcription Factor 4 and Runt-related Transcription Factor 2
J. Biol. Chem., February 29, 2008; 283(9): 5542 - 5553.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. J. Manton, D. F. M. Leong, S. M. Cool, and V. Nurcombe
Disruption of Heparan and Chondroitin Sulfate Signaling Enhances Mesenchymal Stem Cell-Derived Osteogenic Differentiation via Bone Morphogenetic Protein Signaling Pathways
Stem Cells, November 1, 2007; 25(11): 2845 - 2854.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
X. Baraliakos, J. Listing, J. Brandt, H. Haibel, M. Rudwaleit, J. Sieper, and J. Braun
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-{alpha} antibody infliximab
Rheumatology, September 1, 2007; 46(9): 1450 - 1453.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Z.-H. Tang, P. Xiao, S.-F. Lei, F.-Y. Deng, L.-J. Zhao, H.-Y. Deng, L.-J. Tan, H. Shen, D.-H. Xiong, R. R. Recker, et al.
A Bivariate Whole-Genome Linkage Scan Suggests Several Shared Genomic Regions for Obesity and Osteoporosis
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2751 - 2757.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. B. Leonard
Glucocorticoid-Induced Osteoporosis in Children: Impact of the Underlying Disease
Pediatrics, March 1, 2007; 119(Supplement_2): S166 - S174.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. N. WEITZMANN and R. PACIFICI
Estrogen Regulation of Immune Cell Bone Interactions
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 256 - 274.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Lu, L. Gilbert, X. He, J. Rubin, and M. S. Nanes
Transcriptional Regulation of the Osterix (Osx, Sp7) Promoter by Tumor Necrosis Factor Identifies Disparate Effects of Mitogen-activated Protein Kinase and NF{kappa}B Pathways
J. Biol. Chem., March 10, 2006; 281(10): 6297 - 6306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kaneki, R. Guo, D. Chen, Z. Yao, E. M. Schwarz, Y. E. Zhang, B. F. Boyce, and L. Xing
Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts
J. Biol. Chem., February 17, 2006; 281(7): 4326 - 4333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. K. Frick, K. LaPlante, and D. A. Bushinsky
RANK ligand and TNF-{alpha} mediate acid-induced bone calcium efflux in vitro
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1005 - F1011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Xiao, D. Jiang, C. Ge, Z. Zhao, Y. Lai, H. Boules, M. Phimphilai, X. Yang, G. Karsenty, and R. T. Franceschi
Cooperative Interactions between Activating Transcription Factor 4 and Runx2/Cbfa1 Stimulate Osteoblast-specific Osteocalcin Gene Expression
J. Biol. Chem., September 2, 2005; 280(35): 30689 - 30696.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. C. Gilbert, J. Rubin, and M. S. Nanes
The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1011 - E1018.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Jagger, J. M. Lean, J. T. Davies, and T. J. Chambers
Tumor Necrosis Factor-{alpha} Mediates Osteopenia Caused by Depletion of Antioxidants
Endocrinology, January 1, 2005; 146(1): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Qiao, P. Shapiro, R. Kumar, and A. Passaniti
Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway
J. Biol. Chem., October 8, 2004; 279(41): 42709 - 42718.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
T. Nakamoto, A. Shiratsuchi, H. Oda, K. Inoue, T. Matsumura, M. Ichikawa, T. Saito, S. Seo, K. Maki, T. Asai, et al.
Impaired spermatogenesis and male fertility defects in CIZ/Nmp4-disrupted mice
Genes Cells, June 1, 2004; 9(6): 575 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-S. Xiao, A. B. Hjelmeland, and L. D. Quarles
Selective Deficiency of the "Bone-related" Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis
J. Biol. Chem., May 7, 2004; 279(19): 20307 - 20313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Jiang, R. T. Franceschi, H. Boules, and G. Xiao
Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS
J. Biol. Chem., February 13, 2004; 279(7): 5329 - 5337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Redlich, B. Gortz, S. Hayer, J. Zwerina, N. Doerr, P. Kostenuik, H. Bergmeister, G. Kollias, G. Steiner, J. S. Smolen, et al.
Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis
Am. J. Pathol., February 1, 2004; 164(2): 543 - 555.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. Sitcheran, P. C. Cogswell, and A. S. Baldwin Jr.
NF-{kappa}B mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism
Genes & Dev., October 1, 2003; 17(19): 2368 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H Marzo-Ortega, D McGonagle, G Haugeberg, M J Green, S P Stewart, and P Emery
Bone mineral density improvement in spondyloarthropathy after treatment with etanercept
Ann Rheum Dis, October 1, 2003; 62(10): 1020 - 1021.
[Full Text]


Home page
Cancer Res.Home page
J. Pratap, M. Galindo, S. K. Zaidi, D. Vradii, B. M. Bhat, J. A. Robinson, J.-Y. Choi, T. Komori, J. L. Stein, J. B. Lian, et al.
Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts
Cancer Res., September 1, 2003; 63(17): 5357 - 5362.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Kahler and J. J. Westendorf
Lymphoid Enhancer Factor-1 and beta -Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter
J. Biol. Chem., March 28, 2003; 278(14): 11937 - 11944.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.